Werum IT's Welf Ludwig and Immatics Biotechnologies, Ali Mohamed discuss the difficulties surrounding manufacturing CAR-T cell therapies. 

Ahead of the CAR-T congress on April 16th - 17th in Boston, we spoke with Welf Ludwig, Werum IT Solutions (L√ľneburg, Germany), and Ali Mohamed, Immatics Biotechnologies (Tuebingen, Germany), to see how they are tackling manufacturing and scalability challenges. Continue the conversation on manufacturing and meet with both speakers at the CAR-T Congress USA. 

 Visit www.car-tcongress.com for the full agenda and to register to attend. Alternatively, contact Georgia Durham for more details at: events@kisacoresearch.com